Novartis Ag (NVSEF) Total Debt (2009 - 2025)

Novartis Ag has disclosed Total Debt across 13 years of filings, most recently posting $28.7 billion for Q4 2025.

• Total Debt for Q4 2025 came in at $28.7 billion, up 30.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $28.7 billion (up 30.54% YoY), and the FY2025 annual result was $28.7 billion, up 30.54% from the prior year.
• Total Debt came in at $28.7 billion for Q4 2025 at Novartis Ag, down from $30.8 billion in the prior quarter.
• In the past five years, Total Debt ranged from a high of $33.9 billion in Q2 2021 to a low of $19.1 billion in Q4 2023.
• The 5-year median for Total Debt is $28.0 billion (2024), against an average of $27.3 billion.
• Across the five-year window, Total Debt dropped 27.18% in 2023 and soared 30.54% in 2025, its largest moves.
• Novartis Ag's Total Debt stood at $29.2 billion in 2021, then declined by 10.35% to $26.2 billion in 2022, then decreased by 27.18% to $19.1 billion in 2023, then advanced by 15.47% to $22.0 billion in 2024, then jumped by 30.54% to $28.7 billion in 2025.
• The last three Total Debt figures came in at $28.7 billion (Q4 2025), $30.8 billion (Q2 2025), and $22.0 billion (Q4 2024), per Business Quant data.